Related references
Note: Only part of the references are listed.Compartmental and Enzyme Kinetic Modeling To Elucidate the Biotransformation Pathway of a Centrally Acting Antitrypanosomal Prodrug
Claudia N. Generaux et al.
DRUG METABOLISM AND DISPOSITION (2013)
Antiparasitic agents: new drugs on the horizon
Pascal Maeser et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
A Mouse Diversity Panel Approach Reveals the Potential for Clinical Kidney Injury Due to DB289 Not Predicted by Classical Rodent Models
Alison H. Harrill et al.
TOXICOLOGICAL SCIENCES (2012)
Pharmacology of DB844, an Orally Active aza Analogue of Pafuramidine, in a Monkey Model of Second Stage Human African Trypanosomiasis
John K. Thuita et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Trypanocidal Furamidine Analogues: Influence of Pyridine Nitrogens on Trypanocidal Activity, Transport Kinetics, and Resistance Patterns
Christopher P. Ward et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Development of novel drugs for human African trypanosomiasis
Reto Brun et al.
FUTURE MICROBIOLOGY (2011)
Mechanisms Underlying Differences in Systemic Exposure of Structurally Similar Active Metabolites: Comparison of Two Preclinical Hepatic Models
Grace Zhixia Yan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Novel Arylimidamides for Treatment of Visceral Leishmaniasis
Michael Zhuo Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Chemotherapy against human African trypanosomiasis: Is there a road to success?
Christian Burri
PARASITOLOGY (2010)
Focus-Specific Clinical Profiles in Human African Trypanosomiasis Caused by Trypanosoma brucei rhodesiense
Lorna M. MacLean et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Human African Trypanosomiasis in Areas without Surveillance
Francois Chappuis et al.
EMERGING INFECTIOUS DISEASES (2010)
Efficacy of the Novel Diamidine Compound 2,5-Bis(4-Amidinophenyl)-Furan-Bis-O-Methlylamidoxime (Pafuramidine, DB289) against Trypanosoma brucei rhodesiense Infection in Vervet Monkeys after Oral Administration
R. E. Mdachi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
New Treatment Option for Second-Stage African Sleeping Sickness: In Vitro and In Vivo Efficacy of Aza Analogs of DB289
Tanja Wenzler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Antiparasitic compounds that target DNA
W. David Wilson et al.
BIOCHIMIE (2008)
Trypanosoma brucei rhodesiense Transmitted by a Single Tsetse Fly Bite in Vervet Monkeys as a Model of Human African Trypanosomiasis
John K. Thuita et al.
PLOS NEGLECTED TROPICAL DISEASES (2008)
Pharmacokinetics and metabolism of the prodrug DB289 (2,5-bis[4-(N-methoxyamidino)phenyl]furan monomaleate) in rat and monkey and its conversion to the antiprotozoal/antifungal drug DB75 (2,5-bis(4-guanylphenyl)furan dihydrochloride)
Ian Midgley et al.
DRUG METABOLISM AND DISPOSITION (2007)
CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime]
Michael Zhuo Wang et al.
DRUG METABOLISM AND DISPOSITION (2006)
Quantifying the level of under-detection of Trypanosoma brucei rhodesiense sleeping sickness cases
M Odiit et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2005)
In vitro metabolism of an orally active O-methyl amidoxime prodrug for the treatment of CNS trypanosomiasis
JH Ansede et al.
XENOBIOTICA (2005)
Metabolites of an orally active antimicrobial prodrug, 2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime, identified by liquid chromatography/tandem mass spectrometry
L Zhou et al.
JOURNAL OF MASS SPECTROMETRY (2004)
Human African trypanosomiasis of the CNS: current issues and challenges
PGE Kennedy
JOURNAL OF CLINICAL INVESTIGATION (2004)
O-alkoxyamidine prodrugs of furamidine:: In vitro transport and microsomal metabolism as indicators of in vivo efficacy in a mouse model of Trypanosoma brucei rhodesiense infection
JH Ansede et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Distribution and quantitation of the anti-trypanosomal diamidine 2,5-bis(4-amidinophenyl)furan (DB75) and its N-methoxy prodrug DB289 in murine brain tissue
LM Sturk et al.
ACTA TROPICA (2004)
Synthesis and antiprotozoal activity of aza-analogues of furamidine
MA Ismail et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)